LBA62 Efficacy and safety of patritumab deruxtecan (U3-1402), a novel HER3 directed antibody drug conjugate, in patients (pts) with EGFR-mutated (EGFRm) NSCLC

Helena A. Yu, Christina S. Baik, Kathryn A. Gold, Hidetoshi Hayashi, Melissa L. Johnson, Marianna Koczywas, Haruyasu Murakami, Makoto Nishio, Conor Steuer, Wu‐Chou Su, James Chih‐Hsin Yang, Sana D. Karam, Zhenhao Qi, Yang Qiu, S. Chen, Channing Yu, Pasi A. Jänne